Improvements in patient-reported outcomes with teriflunomide: week 24 interim results from the US cohort of the Teri-PRO phase 4 study

被引：0
|
作者：
Coyle, P. K. [1 ]
LaGanke, C. [2 ]
Khatri, B. [3 ]
Edwards, K. [4 ]
Cavalier, S. [5 ]
Baldinetti, F. [5 ]
Brette, S. [6 ]
Gold, R. [7 ]
机构：
[1] SUNY Stony Brook, Stony Brook, NY 11794 USA
[2] North Cent Neurol Associates, Cullman, AL USA
[3] Wheaton Franciscan Healthcare, Reg MS Ctr, Ctr Neurol Disorders, Milwaukee, WI USA
[4] Multiple Sclerosis Ctr Northeastern New York, Latham, NY USA
[5] Genzyme, Cambridge, MA USA
[6] Lincoln, Boulogne, France
[7] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2015年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P562
引用
收藏
页码：261 / 262
页数：2
相关论文
共 50 条
  • [21] Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study
    Larmore, Cynthia J.
    Boytsov, Natalie N.
    Gaich, Carol L.
    Zhang, Xiang
    Araujo, Andre B.
    Rebello, Sabrina
    Salim, Bob A.
    Reed, George W.
    Harrold, Leslie R.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 215 - 229
  • [22] A phase II study of ponesimod in chronic plaque psoriasis: improvements in patient-reported outcomes
    Kemeny, L.
    Yankova, R.
    Talamonti, M.
    Vaclavkova, A.
    Burcklen, M.
    Thomas, G.
    D'Ambrosio, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 21 - 21
  • [23] Patient-Reported Outcomes Over 24 Months in Pediatric CKD: Findings From the MyKidneyHealth Cohort Study
    Amaral, Sandra
    Schuchard, Julia
    Claes, Donna
    Dart, Allison
    Greenbaum, Larry A.
    Massengill, Susan F.
    Atkinson, Meredith A.
    Flynn, Joseph T.
    Dharnidharka, Vikas R.
    Fathallah-Shaykh, Sahar
    Yadin, Ora
    Modi, Zubin J.
    Al-Uzri, Amira
    Wilson, Amy C.
    Dell, Katherine M.
    Patel, Hiren P.
    Bruno, Cortney
    Warady, Bradley
    Furth, Susan
    Forrest, Christopher B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 82 (02) : 213 - +
  • [24] RAPID IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS: 24-WEEK RESULTS OF RAPID-AXSPA STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Coteur, G.
    Woltering, F.
    Landewe, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 287 - 287
  • [25] Patient-reported outcomes to assess quality of life in teriflunomide-treated patients with relapsing-remitting multiple sclerosis: Results of Teri-REAL - a real-world study from Hungary
    Vecsei, L.
    Bencsik, K.
    Dobos, E.
    Jobbagy, Z.
    Birkas, A. Jori
    Kovacs, K.
    Satori, M.
    Bartok, G.
    Losonczi, E.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 708 - 709
  • [26] Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
    Vibeke Strand
    David Fiorentino
    ChiaChi Hu
    Robert M Day
    Randall M Stevens
    Kim A Papp
    Health and Quality of Life Outcomes, 11
  • [27] Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
    Strand, Vibeke
    Fiorentino, David
    Hu, ChiaChi
    Day, Robert M.
    Stevens, Randall M.
    Papp, Kim A.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [28] Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial
    Strand, Vibeke
    Gossec, Laure
    Coates, Laura C.
    Ogdie, Alexis
    Choi, Jiyoon
    Becker, Brandon
    Zhuo, Joe
    Lehman, Thomas
    Nowak, Miroslawa
    Elegbe, Ayanbola
    Mease, Philip J.
    Deodhar, Atul
    ARTHRITIS CARE & RESEARCH, 2024, 76 (08) : 1139 - 1148
  • [29] Patient-reported outcomes (PRO) in patients with metastatic breast cancer (MBC) from the VIRGO observational cohort study (OCS)
    Kaufman, Peter Andrew
    Mayer, Musa
    Dreyer, Nancy A.
    Yim, Yeun Mi
    Yu, Elaine
    Su, Zhaohui
    Mun, Yong
    Sloan, Jeff A.
    Cleeland, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Patient-reported outcomes (PRO) in patients with metastatic breast cancer (MBC) from the VIRGO observational cohort study (OCS)
    Kaufman, Peter Andrew
    Mayer, Musa
    Dreyer, Nancy A.
    Yim, Yeun Mi
    Yu, Elaine
    Su, Zhaohui
    Mun, Yong
    Sloan, Jeff A.
    Cleeland, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
12345